As of Thursday close, MyMD Pharmaceuticals Inc.’s (NASDAQ:MYMD) stock was up $0.17, moving up 10.00 percent to $1.87. The average number of shares traded per day over the past five days has been 2,435,800 shares. 5 times new highs have been achieved over the past 5 days, with a $0.7900 gain in that time frame. In the last twenty days, the average volume was 1,248,440, while in the previous 50 days, it was 754,942.
Since last month, MYMD stock rose 33.57%. Shares of the company fell to $0.8000 on 07/17/23, the lowest level in the past month. A 52-week high of $6.15 was reached on 02/02/23 after having rallying from a 52-week low of $0.80. Since the beginning of this year, MYMD’s stock price has risen by 62.61% or $0.7200, and marked a new high 9 times. However, the stock has declined by -69.59% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
MYMD stock investors should be aware that MyMD Pharmaceuticals Inc. (MYMD) stock had its last reported insider trading activity 239 days ago on Dec 08. Rivard Paul, the EVP of Operations, GC of the company, purchased of 10,000 shares for $1.53 on Dec 08. It resulted in a $15,300 investment by the insider.
The liabilities of MyMD Pharmaceuticals Inc. were 15.31 million at the end of its most recent quarter, and its total debt was $0.13 million. The value of shareholders’ equity is $39.6 million.
Technical Picture
This quick technical analysis looks at MyMD Pharmaceuticals Inc.’s (MYMD) price momentum. With a historical volatility rate of 164.50%, the RSI 9-day stood at 76.55% on 03 August.
With respect to its five-day moving average, the current MyMD Pharmaceuticals Inc. price is up by +73.15% percent or $0.7900. At present, MYMD shares trade +52.03% above its 20-day simple moving average and -8.33% percent below its 100-day simple moving average. However, the stock is currently trading approximately -13.02% below its SMA50 and -19.05% below its SMA200.
Stochastic coefficient K was 86.38% and Stochastic coefficient D was 84.76%, while ATR was 0.2259. Given the Stochastic reading of 80.45% for the 14-day period, the RSI (14) reading has been calculated as 68.15%. As of today, the MACD Oscillator reading stands at 0.3778, while the 14-day reading stands at 0.5079.
Analyst Ratings
MyMD Pharmaceuticals Inc. (MYMD) has been rated Buy by analysts. According to 0 brokerage firms, MYMD is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate MyMD Pharmaceuticals Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $1536.00, the current consensus forecast for the stock is $1536.00 – $1536.00. Based on these forecasts, analysts predict MyMD Pharmaceuticals Inc. (MYMD) will achieve an average price target of $1536.00.
